Pharmacognosy Research logo
Submit
Pharmacognosy ResearchACADEMIC PUBLISHING
Article

Effects of Ligusticum porteri (Osha) Root Extract on Human Promyelocytic Leukemia Cells

1, 1, 1

  1. 1Department of Life Sciences, Texas A&M University–Corpus Christi, Texas, USA.

CORRESPONDENCE

Felix Omoruyi

Department of Life Sciences, Texas A&M University–Corpus Christi, Texas, USA.

felix.omoruyi@tamucc.edu

Volume 9, Issue 2 · pp. 156-160 · 2017 · DOI: 10.4103/0974-8490.204641

ABSTRACT

Background: Ligusticum porteri roots have been traditionally used in folk medicine, but the scientific basis is unclear.Objective: To investigate the cytotoxicity, antioxidant, and immunomodulatory effects of L. porteri root extract on human promyelocytic leukemia (HL‑60) cells and H2O2‑induced oxidative damaged HL‑60 cells.Materials and Methods: HL‑60 cells were incubated with different concentrations of root extract, and cells were harvested for viability assays on day 3 and 7. Cytokine levels (interferon‑gamma [IFN‑γ], interleukin‑2 [IL‑2], and interleukin-10 [IL‑10]) and antioxidant indexes (malondialdehyde [MDA], reduced glutathione [GSH], superoxide dismutase [SOD], and catalase [CAT]) in H2O2‑induced‑stressed HL‑60 were measured after 2 days.Results: The viability of HL‑60 challenged with H2O2 declined by 42% compared to unstressed cells. After 7 days of incubation with 200 or 400 μg/mL L. porteri, the viability of HL‑60 cells was two‑fold higher than the control. Stressed HL‑60 cells treated with 100, 200, and 400 μg/mL L. porteri reduced the lipid peroxidation by 12%–13%. We noted an increase in GSH levels, SOD and CAT activities in stressed HL‑60 supplemented with 400 μg/mL root extract. Treatment with 400 μg/mL L. porteri significantly (P < 0.05) increased IFN‑γ and IL‑2 in H2O2‑challenged cells.Conclusion: Our data do not support the use of the extract as an antiproliferation and differentiation therapy for acute promyelocytic leukemia. The protective function of L. porteri root extract against oxidative stress could occur through increasing GSH and higher expression of antioxidant enzymes.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Nguyen, K., Sparks, J., & Omoruyi, F. (2017). Effects of Ligusticum porteri (Osha) Root Extract on Human Promyelocytic Leukemia Cells. Pharmacognosy Research, 9(2), 156-160. https://doi.org/10.4103/0974-8490.204641

    Copyright and licence

    © 2017 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0